Showing results (341-350 of 468) with videos related to
Sort By:
Pageof 47
Clinical Cardiology|September 11, 2009
Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge careGregory J Fermann, Ali S Raja, Eric D Peterson, et al.Circulation|February 10, 2012
Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data RegistrySumeet Subherwal, Eric D Peterson, Anita Y Chen, et al.Circulation. Cardiovascular Quality and Outcomes|November 18, 2014
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data RegistryRobert W Yeh, Matthew J Czarny, Sharon-Lise T Normand, et al.Journal of the American Heart Association|July 8, 2015
Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary InterventionConnie N Hess, Matthew T Roe, Robert M Clare, et al.American Heart Journal|May 8, 2004
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarctionC Michael Gibson, Juhana Karha, Robert P Giugliano, et al.Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.American Heart Journal|July 11, 2006
Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)Mauricio G Cohen, Matthew T Roe, Jyotsna Mulgund, et al.Journal of the American College of Cardiology|October 22, 2016
The Changing Landscape of Randomized Clinical Trials in Cardiovascular DiseaseW Schuyler Jones, Matthew T Roe, Elliott M Antman, et al.Journal of the American College of Cardiology|January 18, 2006
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromesL Kristin Newby, Matthew T Roe, Anita Y Chen, et al.American Heart Journal|February 9, 2002
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network TrialKenneth W Mahaffey, Matthew T Roe, Christopher K Dyke, et al.Pageof 47